Display Settings:

Format

Send to:

Choose Destination

    Drug Alcohol Depend. 2005 Feb 14;77(2):107-14.

    Cocaine-related fatalities in New South Wales, Australia 1993-2002.

    Darke S, Kaye S, Duflou J.

    National Drug and Alcohol Research Centre, University of New South Wales, NSW 2052, Australia. s.darke@unsw.edu.au

    AIM: To ascertain the demographic characteristics, circumstances of death, toxicological results, and major autopsy findings of cocaine-related fatalities. DESIGN: Inspection of the coronial records of all cocaine-related deaths that occurred in New South Wales, Australia between 1 January 1993 and 31 December 2002. SETTING: New South Wales, Australia. FINDINGS: 146 cases were identified. Cocaine was implicated in the direct cause of death in 86% of cases, an antecedent cause in 8% and a significant condition contributing to death in 7%. The mean age of decedents was 34.1 years, and 84% were male. Half were employed, and 26% were in professional employment. The predominant route of administration was injection (86%), however nasal (8%), oral (3%), smoking (1%), and anal (1%) administration were all recorded. The most common location of death was a private home (53%). No intervention occurred prior to death in 82% of cases. The median blood benzoylecgonine concentration was 0.40 mg/L (range 0.00-20.00 mg/L). Cases had a mean of 3.5 drugs, with morphine (79%) the most common co-occurring drug. In 5% of cases cocaine was the sole drug detected. Cardiac pathology was noted in 57% of cases, most commonly coronary artery atherosclerosis (39%) and cardiac hypertrophy (14%). In 15% of cases moderate to severe arterial occlusion was noted. Cerebrovascular pathology was noted in 22% of cases, most commonly cerebrovascular atherosclerosis (10%). CONCLUSIONS: Cocaine-related deaths are a significant clinical problem in New South Wales.

    PMID: 15664712 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read Click here to read Click here to read

    Patient drug information

    • Morphine Sulfate Injection (Astramorph/PF®, Duramorph®, Infumorph®)

      Your doctor has ordered morphine, a strong analgesic (painkiller), to relieve your pain. The drug will be either injected into a large muscle (such as your buttock or hip) or added to an intravenous fluid that will drip ...

    • Morphine Oral (Avinza®, Kadian®, MS Contin®, ...)

      Morphine is used to relieve moderate to severe pain. Morphine long-acting tablets and capsules are only used by patients who are expected to need medication to relieve moderate to severe pain around-the-clock for longer ...